Board Erred In Shifting Burden To Patent Owner, Federal Circuit Rules
WASHINGTON, D.C. — A final written decision by the Patent Trial and Appeal Board that invalidated various claims of a patented prostate cancer treatment was vacated and remanded Feb. 5 by...To view the full article, register now.
Already a subscriber? Click here to view full article